Next Article in Journal
Vitamin B6 and Its Role in Cell Metabolism and Physiology
Next Article in Special Issue
GABAB Receptors Augment TRPC3-Mediated Slow Excitatory Postsynaptic Current to Regulate Cerebellar Purkinje Neuron Response to Type-1 Metabotropic Glutamate Receptor Activation
Previous Article in Journal
TRPM2 in the Brain: Role in Health and Disease
Previous Article in Special Issue
TRP Channel Involvement in Salivary Glands—Some Good, Some Bad
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessFeature PaperReview
Cells 2018, 7(7), 83; https://doi.org/10.3390/cells7070083

TRPC3 as a Target of Novel Therapeutic Interventions

Gottfried-Schatz-Research-Center—Biophysics, Medical University of Graz, Neue Stiftingtalstrasse 6/D04, 8010 Graz, Austria
*
Author to whom correspondence should be addressed.
Received: 10 June 2018 / Revised: 18 July 2018 / Accepted: 20 July 2018 / Published: 22 July 2018
(This article belongs to the Special Issue TRP Channels in Health and Disease)
View Full-Text   |   Download PDF [910 KB, uploaded 22 July 2018]   |  

Abstract

TRPC3 is one of the classical members of the mammalian transient receptor potential (TRP) superfamily of ion channels. TRPC3 is a molecule with intriguing sensory features including the direct recognition of and activation by diacylglycerols (DAG). Although TRPC3 channels are ubiquitously expressed, they appear to control functions of the cardiovascular system and the brain in a highly specific manner. Moreover, a role of TRPC3 in immunity, cancer, and tissue remodeling has been proposed, generating much interest in TRPC3 as a target for pharmacological intervention. Advances in the understanding of molecular architecture and structure-function relations of TRPC3 have been the foundations for novel therapeutic approaches, such as photopharmacology and optochemical genetics of TRPC3. This review provides an account of advances in therapeutic targeting of TRPC3 channels. View Full-Text
Keywords: transient receptor potential channels; TRPC3 pharmacology; channel structure; lipid mediators; photochromic ligands transient receptor potential channels; TRPC3 pharmacology; channel structure; lipid mediators; photochromic ligands
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Tiapko, O.; Groschner, K. TRPC3 as a Target of Novel Therapeutic Interventions. Cells 2018, 7, 83.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cells EISSN 2073-4409 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top